This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Kamil Kruczek: Innovator in Gene Therapy
Introduction
Kamil Kruczek is a prominent inventor based in Bethesda, MD (US). He has made significant contributions to the field of gene therapy, particularly in the treatment of genetic disorders affecting vision.
Latest Patents
Kamil Kruczek holds a patent titled "Gene Therapy for Treatment of CRX-Autosomal Dominant Retinopathies." This innovative approach aims to address specific genetic conditions that lead to vision loss, showcasing his commitment to advancing medical science.
Career Highlights
Kruczek is affiliated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work in this esteemed organization highlights his dedication to public health and innovative research.
Collaborations
Throughout his career, Kamil has collaborated with notable colleagues, including Zhijian Wu and Anand Swaroop. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking therapies.
Conclusion
Kamil Kruczek's contributions to gene therapy exemplify the impact of innovative thinking in medicine. His work not only addresses critical health issues but also inspires future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile